Commercial α1-antitrypsin preparations markedly differ in their potential to inhibit the ATP-induced release of monocytic interleukin-1β

Publication date: Available online 25 March 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): A. Agné, K. Richter, W. Padberg, S. Janciauskiene, V. Grau
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research